COMPLETE List of Steroids: Benefits & Risks with & without Testosterone – Doctor’s Analysis

The transcript frames itself as a single encyclopedia style guide covering anabolic steroid history and use. It states that hundreds of separate videos exist, but one consolidated overview is being attempted here. A core organizing idea is sorting compounds into cutting, bulking, and extreme no fly categories for clarity. Cutting is described as fat loss, muscle preservation, and a dry look prized in physique competition culture. The segment names common cutting drugs like Anavar, Winstrol, and Tren, while noting very different responses. DHT derived choices are highlighted for hardness, with discussion of androgenic tradeoffs and side effects. The overall tone emphasizes harm reduction, not endorsement, while encouraging fact based understanding.

Bulking is introduced as mass, strength, and scale gains that often come with more water and pressure. Testosterone is discussed as a foundational bulking agent, especially when aromatizing effects are tolerated. Oral bulking drugs like Dianabol and Anadrol are referenced for rapid strength but heavier side effect burdens. The discussion explains that estrogenic and progesteronic signaling can change mood, libido, and wellbeing. Longer acting injectables such as Equipoise and Deca are mentioned as options people combine with Tren. The transcript repeatedly references lab monitoring, including AST and ALT, to track potential liver stress. It stresses that genetics, dosing, and concurrent drugs make simple potency rankings unreliable in practice.

A no fly zone is described for exceptionally dangerous compounds that should trigger extra caution. Examples include Halotestin, MENT, and dimethyltrienolone, which are framed as potent but toxic agents. A specific warning about massive liver toxicity is given for certain trend like oral steroid variants. The segment also mentions blood pressure concerns and hypertension risk as part of cardiovascular strain. Heart and kidney consequences are referenced as long term outcomes that may appear later in life. The closing message emphasizes education so people can avoid denial and recognize tradeoffs early. It ends by calling for broader harm reduction awareness for men and women who encounter these drugs.